ClinicalTrials.gg
Status unknownNCT01891877Updated Oct 20, 2014

Sickle Cell Trait in Football Players

An observational study in Sickle Cell Trait, sponsored by University of South Florida. Status unknown at 1 site in United States. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-10-20.

Sponsored by University of South Florida · Observational

The sponsor has not verified this record recently (last verified Oct 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
20
Ages
18 Years and older
Sex
Male
01

Study summary

This study will look at the five different types of sickle cell and their relation to self-reported ill health to determine whether or not one or two of the sickle cell haplotypes are correlated with worse health outcomes. Participants can do complete the study in under half an hour in the privacy of their own home.

Read the detailed description

Sickle cell anemia is a disease which results from the inheritance of two hemoglobin S (Hb S) genes. Sickle-cell anemia individuals are referred to as Hb SS patients, and are known to suffer from a variety of life-threatening symptoms. Paramount in the clinical complications of sickle cell patients is the "sickle-cell crisis". If a crisis is not stopped by prompt medical attention, it may result in death. It is becoming increasingly clear that some sickle cell anemic patients have more benign clinical profiles than do others. The genetic reason for such clinical differences has been well determined: although the mutation that changes the "normal" hemoglobin gene is the same in all patients, the genetic material outside of the gene influences how the gene is expressed. This genetic material is referred to as the beta-globin haplotype. Carriers of the sickle cell gene are referred to as Hb AS individuals. Hb AS carriers usually have a normal life free of the clinical problems associated with the disease suffered by sickle cell patients. However, it is becoming increasingly clear that under strenuous situations, some Hb AS carriers do experience heat illness and other life threatening problems while others do not. The purpose of this project is to determine if there is a genetic reason for why some athlete carriers of the sickle cell trait experience heat illness, while others do not. Although the genetic reason for the different clinical outcomes of sickle cell anemic patients is now well understood (different haplotypes result in different disease courses), the possibility that the same haplotypes might be the reason why some sickle cell carriers have worse clinical profiles has never been explored. In this project we will work with a sickle-cell trait registry of athletes, and we will test the haplotypes of Hb AS athletes who have and who have not had heat illness. Our study is the first to attempt to clarify if there is a genetic reason for this occurrence. Total participation time for the study is thirty minutes or less. Information provided by the participant will be analyzed within one year of participation. Deidentified results will be kept for five years, per the University of South Florida's Institutional Review Board protocol, and will be available upon request to the principal investigator. Participants can do complete the study in under half an hour in the privacy of their own home.

02

Conditions studied

  • Sickle Cell Trait

Keywords

  • Sickle Cell Trait
  • Football
  • Sickling
  • Heat Illness
  • SCT
03

In context

Sickle Cell Trait

43 studies on the registry are indexed under Sickle Cell Trait; 11 are open to participants now.

This study's planned enrollment of 20 is below the median of 109 across 20 observational studies indexed under Sickle Cell Trait.

Browse Sickle Cell Trait studies →

Lead sponsor

University of South Florida is the lead sponsor of 340 studies on the registry; 65 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of adult males who currently or formerly played high school or college football and know that they carry sickle cell trait.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • over the age of 18
  • male
  • has previously played or currently plays high school or college football
  • carries sickle cell trait

Exclusion criteria

Exclusion Criteria:

  • under the age of 18
  • female
  • does not carry sickle cell trait
  • has not played or does not play high school or college football
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
20 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Current or Former Football Players

    Any former or current high school or college football players who carries sickle cell trait.

06

What researchers measure

Primary outcomes

  1. Poor health outcomes

    Any ill health events, such as excessive dehydration, muscle cramping, fatigue, shortness of breath, sickling crises, that can be linked to a sickling event.

    Time frame: 30 minutes or less to complete survey and buccal swab

07

Study locations

1 of 1 sites recruiting
  • University of South Florida
    Tampa, Florida 33620, United States
    Recruiting
    • Carroll N Flansburg, in progress · Principal investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 20, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01891877
Responsible party
Carroll Flansburg (Research Coordinator, University of South Florida) — Principal investigator
First posted
Jul 3, 2013
Start date
Oct 2012
Primary completion
Dec 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Oct 20, 2014

Study contacts

Carroll N Flansburg, in progress
Contact
cflansbu@mail.usf.edu
8025851054
Lorena Madrigal, PhD Anthropology
Contact
madrigal@usf.edu
8139742138
Carroll N Flansburg, in progress
principal investigator · University of South Florida

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion